Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, Oregon, USA.
Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, Oregon, USA; Department of Medical Biochemistry, Tanta University, Tanta, Egypt.
J Biol Chem. 2020 Dec 11;295(50):17281-17297. doi: 10.1074/jbc.RA120.015489. Epub 2020 Oct 9.
The adipocyte-derived hormone leptin increases trafficking of K and Kv2.1 channels to the pancreatic β-cell surface, resulting in membrane hyperpolarization and suppression of insulin secretion. We have previously shown that this effect of leptin is mediated by the NMDA subtype of glutamate receptors (NMDARs). It does so by potentiating NMDAR activity, thus enhancing Ca influx and the ensuing downstream signaling events that drive channel trafficking to the cell surface. However, the molecular mechanism by which leptin potentiates NMDARs in β-cells remains unknown. Here, we report that leptin augments NMDAR function via Src kinase-mediated phosphorylation of the GluN2A subunit. Leptin-induced membrane hyperpolarization diminished upon pharmacological inhibition of GluN2A but not GluN2B, indicating involvement of GluN2A-containing NMDARs. GluN2A harbors tyrosine residues that, when phosphorylated by Src family kinases, potentiate NMDAR activity. We found that leptin increases phosphorylation of Tyr-418 in Src, an indicator of kinase activation. Pharmacological inhibition of Src or overexpression of a kinase-dead Src mutant prevented the effect of leptin, whereas a Src kinase activator peptide mimicked it. Using mutant GluN2A overexpression, we show that Tyr-1292 and Tyr-1387 but not Tyr-1325 are responsible for the effect of leptin. Importantly, β-cells from mice, a type 2 diabetes mouse model lacking functional leptin receptors, or from obese diabetic human donors failed to respond to leptin but hyperpolarized in response to NMDA. Our study reveals a signaling pathway wherein leptin modulates NMDARs via Src to regulate β-cell excitability and suggests NMDARs as a potential target to overcome leptin resistance.
脂肪细胞衍生的激素瘦素增加了 K 和 Kv2.1 通道向胰腺β细胞表面的转运,导致膜超极化和胰岛素分泌抑制。我们之前已经表明,瘦素的这种作用是通过 NMDA 型谷氨酸受体(NMDARs)介导的。它通过增强 NMDAR 活性来实现,从而增强 Ca2+内流和随后驱动通道转运到细胞表面的下游信号事件。然而,瘦素在β细胞中增强 NMDAR 的分子机制尚不清楚。在这里,我们报告说,瘦素通过Src 激酶介导的 GluN2A 亚基磷酸化增强 NMDAR 功能。瘦素诱导的膜超极化在 GluN2A 的药理学抑制后减弱,但在 GluN2B 抑制后不减弱,表明涉及含有 GluN2A 的 NMDAR。GluN2A 具有酪氨酸残基,当被 Src 家族激酶磷酸化时,增强 NMDAR 活性。我们发现瘦素增加了Src 中 Tyr-418 的磷酸化,这是激酶激活的一个指标。Src 的药理学抑制或激酶失活 Src 突变体的过表达阻止了瘦素的作用,而 Src 激酶激活肽模拟了它的作用。使用突变 GluN2A 的过表达,我们表明 Tyr-1292 和 Tyr-1387 但不是 Tyr-1325 对瘦素的作用负责。重要的是,缺乏功能性瘦素受体的 2 型糖尿病小鼠模型或肥胖糖尿病供体的β细胞对瘦素没有反应,但对 NMDA 有反应。我们的研究揭示了一种信号通路,其中瘦素通过 Src 调节 NMDAR 以调节β细胞兴奋性,并表明 NMDAR 是克服瘦素抵抗的潜在靶点。